Arcturus Therapeutics (ARCT) vs Emergent BioSolutions (EBS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
Emergent BioSolutions (EBS) has outperformed Arcturus Therapeutics (ARCT) over the past year, losing 28.7% versus a loss of 37.6%. Over five years, ARCT leads with a -72.0% price change compared with -86.1% for EBS. Arcturus Therapeutics is the larger company by market cap ($362.8 million vs $362.5 million), about 1.0 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | ARCT | EBS |
|---|---|---|
| Share price | $12.77 | $7.07 |
| Market cap | $362.82M | $362.50M |
| 1-day change | -1.81% | +1.73% |
| YTD return | +108.24% | -42.80% |
| 1-year return | -37.64% | -28.73% |
| 5-year return | -71.98% | -86.05% |
| Forward P/E | — | 6.76 |
| EPS (TTM) | $-3.33 | $-3.40 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $24.17 | $14.06 |
| 52-week low | $5.50 | $4.36 |
| Distance from 52-week high | -47.19% | -49.72% |
| Average volume | 938.70K | 1.16M |
| Shares outstanding | 28.42M | 51.27M |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations | Biotechnology: Pharmaceutical Preparations |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
ARCT vs EBS FAQ
Which is bigger, Arcturus Therapeutics or Emergent BioSolutions?
Arcturus Therapeutics (ARCT) is larger, with a market capitalization of $362.82M compared with $362.50M for Emergent BioSolutions (EBS).
Which stock has performed better over the past year, ARCT or EBS?
EBS returned -28.73% over the past 12 months, compared with -37.64% for ARCT (price return, excluding dividends). Past performance does not predict future results.
Are Arcturus Therapeutics and Emergent BioSolutions in the same industry?
Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.